Already Registered? Log In Now
Not Registered?
Business Email:
Complete this form to enter the webcast.
Already Registered?
(* indicates required field)
Complete this form to enter the webcast.
(* indicates required field)
Business Email*:
First Name*:
Last Name*:
Job Title*:
Company Name*:
Street Address 1*:
Street Address 2:
City*:
State/Province*:
--
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
Postal Code*:
Country*:
--
Afghanistan
Aland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia, Plurinational State of
Bonaire, Sint Eustatius and Saba
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Congo, The Democratic Republic of the
Cook Islands
Costa Rica
Côte d'Ivoire
Croatia
Cuba
Curaçao
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands (Malvinas)
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island and McDonald Islands
Holy See (Vatican City State)
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran, Islamic Republic of
Iraq
Ireland
Isle of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Korea, Democratic People's Republic of
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libyan Arab Jamahiriya
Liechtenstein
Lithuania
Luxembourg
Macao
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia, Federated States of
Moldova, Republic of
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North Macedonia, Republic of
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory, Occupied
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Réunion
Romania
Russian Federation
Rwanda
Saint Barthélemy
Saint Helena
Saint Kitts and Nevis
Saint Lucia
Saint Martin (French Part)
Saint Pierre and Miquelon
Saint Vincent and the Grenadines
Samoa
San marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Sint Maarten (Dutch Part)
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the South Sandwich Islands
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan
Tajikistan
Tanzania, United Republic of
Thailand
Timor-leste
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States Minor Outlying Islands
United States of America
Uruguay
Uzbekistan
Vanuatu
Venezuela, Bolivarian Republic of
Viet Nam
Virgin Islands, British
Virgin Islands, U.S.
Wallis and Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
Business Phone:
Which best describes your job function?:
--
Clinical Research
Commercial Operations
Commercialization
Compliance
Consultant
Contract Services
Corporate Management
Drug Safety
Engineering
Environmental
Finance
HR
IT
Lab Management
Legal
Managed Care
Manufacturing/Processing
Market Research
Marketing
Media Planning
Medical Affairs
Medicare/Medicaid
Meeting Planner
Other
Packaging
Patient Programs/Services
Pharmacy
Procurement
Project Management
QA/QC
R&D
Regulatory Affairs
Reimbursement
Sales Management
Scientific
Supply Chain
Technology Transfer
Trade/Sales
Validation
X-Outcomes
Which best describes your business/industry?:
--
Academic
Audit & Financial Advisory
Biopharma
Bio Pharmaceutical
Biotech
Consultant
Contract Manufacturing Organization (CMO)
Contract Research Organization (CRO)
Convention/Visitors Bureau
Data Management/Technology Provider
Diagnostics
DMC (Destination Management Company)
Food
Government
Health Plan/Payer
Hospital/Medical Centers
Hotel
Laboratory
Legal/Law Firm
Marketing/Creative Agency
Medical Device
Non Profit
PBM (Pharmacy Benefit Management)
Pharmaceutical
Retail Pharmacy
Solutions Provider
Third Party Meeting Manager
Wholesaler/Distributer
checked
Yes, please subscribe me to Pharmaceutical Technology's free e-newsletters.
Do you have any early stage molecules that need outsourcing ?:
--
Right now
In the next 3 to 6 months
In the next 12 months
No need, research only
By registering for this event, you agree to MJH Life Sciences ®
Terms and Conditions
,
Privacy Policy
, and understand your data will be used by MJH and its affiliates for amongst other things, alerting you to other services or products that you maybe interested in, and may be shared with or sold to third parties for their use, including possible contact with you through email or other communications, consistent with their respective privacy policy. If you do not agree to have your data used in this way, please contact
info@mjhassoc.com
.
*Denotes required.
Pave an Expressway to Phase I –Strategies That Accelerate Your Early Phase Programs
Thu, Apr 6, 2023 11:00 AM EDT{LOCAL_TZ}
Event Overview
The success of any new drug development starts in its early phase. The probability of success of a molecule increases dramatically after it passes first-in-human (FIH) and proof-of-concept (POC) studies. Building a comprehensive understanding of the molecule is crucial to successful early phase development. API salt form and formulation selections are also key factors to successful phase I studies. Effective CMC strategies can significantly enhance the speed of early phase development and ultimately the chance for success in late-stage development.
Solid state studies not only provide a fundamental understanding of a molecule but also serve as a platform that leverages the knowledge from API development and manufacturing, which can further enhance the speed of early-phase development. With more than 70% of new chemical entities being poorly soluble, having a comprehensive bioavailability enhancement toolbox and strategies is critical to success in the early phase. This webinar will present our experience in using the integrated API and drug product platform and formulation technologies to accelerate early-phase development to phase I and beyond.
Key Learning Objectives
Key considerations in early stage drug development
The role of salt form and polymorph screening in early stage development
Formulation strategies to accelerate the path to phase I with a better chance of success.
Who Should Attend
Biotechnology innovators
Drug developers
Formulation and analytical chemists
Featured Speakers
Xiaoyang Wang, Ph.D.
Executive Director, Head of Solid State Development
WuXi STA
Dr. Xiaoyang Wang
joined WuXi STA in 2018 and established Solid State Development (SSD) team. As part of STA integrated CMC platform, the team focuses on solid form screening, solid state characterization, powder characterization, and material science. It provides solutions to drug substance and drug product development in preclinical, clinical, and commercial stages. He has more than 10 years of experience in form selection, solid state characterization, crystallization, drug development, and organic chemistry. Before joining WuXi STA, Dr. Wang was a solid state expert in Novartis. He has multiple patents in various areas and published more than 10 papers in peer-reviewed scientific journals.
Dr. Wang
worked as a postdoctoral researcher in chemical biology at the Eshelman School of Pharmacy, University of North Carolina at Chapel Hill. He received his Ph.D. in Organic Chemistry from the University of Cincinnati, Master’s and Bachelor’s degrees in Environmental Engineering from the Nanjing University of Science and Technology.
Santipharp Panmai, Ph.D
Vice President, Head of Formulation Development
WuXi STA
Dr. Santipharp Panmai
is the Vice President and the head of formulation development at WuXi STA, a subsidiary of WuXi AppTec since 2017. He leads formulation teams in Shanghai and Wuxi, China, responsible for formulation development and clinical trial materials of new chemical entities from global clients (US, Europe, and Asia).Before joining WuXi STA, he worked at MSD in the US (PA/NJ) for 18 years in the Pharmaceutical Sciences group. He has extensive experience in formulation development and material characterization.
Dr. Panmai
obtained his B.S. in Chemical Engineering from the University of California at Berkeley and his Ph.D. in Chemical Engineering from Princeton University.
For any technical questions please contact Kristina Dunphey:
kdunphey@mjhlifesciences.com
.
FAQs and System Test
Outlook ❯
Google ❯